查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1702348

全球診斷影像市場 - 2025-2033

Global Diagnostic Imaging Market - 2025-2033
出版日期: | 出版商: DataM Intelligence | 英文 180 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

2024 年全球診斷影像市場規模達到 299.3 億美元，預計到 2033 年將達到 462.5 億美元，在 2025-2033 年預測期內的複合年成長率為 4.9%。

診斷影像涵蓋多種用於創建身體內部視覺表現的醫療技術，使醫療保健專業人員能夠診斷、監測和治療各種疾病。這些影像方法包括 X 光、CT 掃描、MRI、超音波和核子醫學，可提供詳細的影像，幫助醫生識別症狀的根本原因，例如疼痛、腫脹或身體檢查中的異常發現。

除了診斷之外，診斷影像在監測骨折、腫瘤、感染或慢性疾病等治療進展方面也發揮關鍵作用。透過提供一種非侵入性的方式來檢查身體內部結構，診斷影像對於準確、及時的醫療干預和持續的患者護理至關重要。

市場動態：

駕駛員和約束裝置

慢性病發生率上升

慢性病和病理疾病的日益普及對先進的診斷影像技術產生了巨大的需求。隨著對早期發現併發症的需求增加，診斷影像設備市場迅速擴大。這些影像程序利用放射線照相術、超音波檢查、透視檢查和核子醫學等技術，提供身體內部的詳細視覺影像，對於診斷各種慢性疾病至關重要。透過這些方法診斷的最常見疾病包括心血管疾病、癌症、慢性呼吸系統疾病和糖尿病。

例如，根據美國國家骨質疏鬆症基金會的數據，美國有 1,020 萬人患有骨質疏鬆症，女性的盛行率（16.5%）高於男性（5.1%）。此外，還有4,340萬人骨量低。預計到 2030 年，將有 7,100 萬成年人患有骨質疏鬆症或骨質不足。同樣，美國癌症協會的《2024 年全球癌症統計報告》強調，2022 年全球診斷出約 2,000 萬例新癌症病例，其中 970 萬人死於癌症。到2050年，全球癌症病例數預計將上升至3,500萬人。隨著這些慢性疾病的不斷增加，對診斷影像的需求不斷成長，推動了市場的擴張。

診斷影像系統的高成本

診斷成像系統的高成本預計將對診斷成像市場的成長構成重大挑戰。這些先進技術，例如 MRI 機器、CT 掃描儀和 PET 掃描儀，需要大量的前期投資用於購買和安裝，以及持續的維護和營運費用。

對於許多醫療機構來說，購買和維護這些複雜系統的財務負擔可能是難以承受的。因此，診斷影像系統的高成本可能會減緩市場的成長，特別是在醫療保健預算已經捉襟見肘的地區。

目錄

第1章：市場介紹和範圍

  • 報告目標
  • 報告範圍和定義
  • 報告範圍

第2章：高階主管見解與關鍵要點

  • 市場亮點和戰略要點
  • 主要趨勢和未來預測
  • 按類型分類的程式碼片段
  • 按應用程式截取的程式碼片段
  • 最終用戶的程式碼片段
  • 按地區分類

第3章：動態

  • 影響因素
    • 驅動程式
      • 慢性病發生率上升
      • 先進產品創新不斷湧現
    • 限制
      • 診斷成像系統成本高昂
      • 缺乏熟練的專業人員
    • 機會
      • 技術進步
    • 影響分析

第4章：戰略洞察與產業展望

  • 市場領導者和先驅者
    • 新興先鋒和傑出參與者
    • 擁有最大銷售品牌的成熟領導者
    • 擁有成熟產品的市場領導者
  • CXO 觀點
  • 最新進展與突破
  • 案例研究/正在進行的研究
  • 監管和報銷情況
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 波特五力分析
  • 供應鏈分析
  • 專利分析
  • SWOT分析
  • 未滿足的需求和差距
  • 市場進入和擴張的推薦策略
  • 情境分析：最佳情況、基本情況和最壞情況預測
  • 定價分析和價格動態
  • 關鍵意見領袖

第5章：診斷影像市場（按類型）

  • 磁振造影
    • 低場MRI掃描儀
    • 高場MRI掃描儀
    • 中場MRI掃描儀
  • X光
    • 類比成像
    • 數位影像
  • 核子醫學
    • 閃爍掃描
    • PET影像
    • SPECT 影像
  • 超音波
    • 2D超音波
    • 3D/4D超音波
    • 多普勒成像
  • 斷層掃描
    • 高階切片CT掃描儀
    • 中端切片CT掃描儀
    • 低階切片CT掃描儀
  • 觸覺成像
  • 功能性近紅外光譜

第6章：診斷影像市場（按應用）

  • 骨科
    • 關節炎
    • 骨折和脫位
    • 骨質疏鬆症
    • 脊椎矯正術
    • 其他
  • 神經病學
    • 腦腫瘤
    • 創傷性腦損傷
    • 腦中風
    • 其他
  • 腫瘤學
    • 乳癌
    • 大腸直腸癌
    • 肺癌
    • 其他癌症
  • 其他

第7章：診斷影像市場（按最終用戶）

  • 診斷影像中心
  • 醫院
  • 其他

第 8 章：診斷影像市場，按區域市場分析和成長機會

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 歐洲其他地區
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 阿根廷
    • 拉丁美洲其他地區
  • 亞太
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 中東和非洲

第9章：競爭格局與市場定位

  • 競爭概況和主要市場參與者
  • 市佔率分析與定位矩陣
  • 策略夥伴關係、併購
  • 產品組合和創新的關鍵發展
  • 公司基準化分析

第10章：公司簡介

  • GE HealthCare
    • 公司概況
    • 產品組合
      • 產品描述
      • 產品關鍵績效指標 (KPI)
      • 歷史和預測產品銷售
      • 產品銷售量
    • 財務概覽
      • 公司收入
      • 地區收入佔有率
      • 收入預測
    • 關鍵進展
      • 併購
      • 關鍵產品開發活動
      • 監管部門批准等
    • SWOT分析
  • Siemens Healthineers AG
  • Carestream Health
  • Hitachi Medical Corporation
  • Canon Medical Systems Corporation
  • Hologic, Inc.
  • Koninklijke Philips NV
  • Fujifilm Holdings Corporation
  • Shimadzu Corporation
  • Mindray

第 11 章：假設與研究方法

  • 資料收集方法
  • 數據三角測量
  • 預測技術
  • 數據驗證和確認

第 12 章：附錄

簡介目錄
Product Code: MI390

The global diagnostic imaging market reached US$ 29.93 billion in 2024 and is expected to reach US$ 46.25 billion by 2033, growing at a CAGR of 4.9% during the forecast period of 2025-2033.

Diagnostic imaging encompasses a variety of medical techniques used to create visual representations of the interior of the body, enabling healthcare professionals to diagnose, monitor, and treat various conditions. These imaging methods, which include X-rays, CT scans, MRIs, ultrasounds, and nuclear medicine, provide detailed images that help doctors identify the underlying causes of symptoms, such as pain, swelling, or unusual findings in physical exams.

Beyond diagnosis, diagnostic imaging also plays a key role in monitoring the progress of treatments for conditions like fractures, tumors, infections, or chronic diseases. By offering a non-invasive way to examine the body's internal structures, diagnostic imaging is essential for accurate, timely medical intervention and ongoing patient care.

Market Dynamics: Drivers & Restraints

Increasing Incidence of Chronic Diseases

The growing prevalence of chronic and pathological conditions has created a significant demand for advanced diagnostic imaging technologies. As the need for early detection of complications increases, the market for diagnostic imaging equipment has expanded rapidly. These imaging procedures, which utilize techniques such as radiography, ultrasonography, fluoroscopy, and nuclear medicine, provide detailed internal visuals of the body and are essential for diagnosing a variety of chronic disorders. Among the most common conditions diagnosed through these methods are cardiovascular disease, cancer, chronic respiratory disorders, and diabetes.

For example, according to the National Osteoporosis Foundation, 10.2 million people in the U.S. are affected by osteoporosis, with women experiencing a higher prevalence (16.5%) than men (5.1%). Additionally, 43.4 million people have low bone mass. It's projected that by 2030, 71 million adults will have osteoporosis or poor bone mass. Similarly, the American Cancer Society's 2024 Global Cancer Statistics report highlighted that approximately 20 million new cancer cases were diagnosed worldwide in 2022, with 9.7 million deaths attributed to the disease. By 2050, the global number of cancer cases is expected to rise to 35 million. As these chronic diseases continue to increase, the demand for diagnostic imaging continues to grow, driving the expansion of the market.

High Costs of Diagnostic Imaging Systems

The high costs associated with diagnostic imaging systems are expected to pose a significant challenge to the growth of the diagnostic imaging market. These advanced technologies, such as MRI machines, CT scanners, and PET scanners, require substantial upfront investment for purchasing and installation, as well as ongoing expenses for maintenance and operation.

For many healthcare facilities, the financial burden of acquiring and maintaining these sophisticated systems can be prohibitive. As a result, the high costs associated with diagnostic imaging systems are likely to slow down the market's growth, especially in regions where healthcare budgets are already stretched.

Segment Analysis

The global diagnostic imaging market is segmented based on type, application, end-user, and region.

MRI in the type segment is expected to dominate the diagnostic imaging market

The MRI segment is expected to hold a significant portion of the market share. This is because of their ability to produce detailed images of organs, as well as technological advances in product innovation. Magnetic resonance imaging (MRI) is a diagnostic tool that can generate detailed images of almost any structure or organ in the body.

MRI produces images on a computer using magnets and radio waves. The images produced by an MRI scan can include organs, bones, muscles, and blood arteries. Hospitals and diagnostic centers often prefer advanced, emerging, and innovative MRI solutions to diagnose diseases in the body, which is creating a demand for MRI systems.

MRI systems play a crucial role in disease detection, diagnosis, and treatment monitoring, particularly in identifying early changes in tissue and organ structures. This capability enables the earlier detection of conditions such as cancer, neurological disorders, and musculoskeletal diseases. As the prevalence of diseases affecting the brain, spinal cord, nerves, muscles, ligaments, and tendons continues to rise, there is an increasing demand for MRI technology to accurately detect, diagnose, and manage these conditions.

For instance, a 2024 report by the National Cancer Institute reveals that in the United States, over 110 million adolescents and young adults (AYAs) between the ages of 15 and 39 are living, with approximately 208,620 of them diagnosed with primary brain or spinal cord tumors. With the incidence of brain cancer expected to grow, the demand for MRI systems is anticipated to increase accordingly.

In addition, advancements in MRI technology by medical device manufacturers are expected to further propel market growth. For instance, in October 2024, FUJIFILM Healthcare Americas Corporation launched the Version 10 (v10) suite of upgrades for its ECHELON Synergy 1.5T MRI system. The v10 model integrates cutting-edge technologies, including Synergy DLR Clear, Synergy Vision with StillShot, and enhanced automated scanning capabilities, offering improved imaging precision and faster diagnostics.

With the rising number of neurological and musculoskeletal conditions, along with the ongoing innovation in MRI systems, the demand for advanced MRI solutions is poised to grow, driving the expansion of this market segment.

Geographical Analysis

North America is expected to dominate the diagnostic imaging market

The diagnostic imaging market in North America is driven by the increasing incidence of chronic diseases, the innovation of advanced systems, and also due to the presence of a large number of market players. The increasing applications of diagnostic imaging for various purposes and the presence of reimbursements in the region are expected to contribute to the region's market growth.

Moreover, North America adopts advanced technologies and systems in the healthcare industry, which could create a lucrative opportunity for the region's diagnostic imaging market growth. Cancer, cardiovascular disease, and osteoarthritis are rising among elderly individuals, raising the need and utilization of different diagnostics such as X-rays, MRIs, and CT scans. For instance, according to a report published by the Centers for Disease Control and Prevention in 2024, Heart abnormalities impact around 40,000 babies annually in the United States.

Similarly, according to the CDC revised report in 2024, approximately 53.2 million persons in the US suffer from arthritis. There are over 100 forms of arthritis, but osteoarthritis is the most common, affecting 32.5 million US people. With the rising abnormalities, the demand for diagnostic imaging rises. This transition has increased market demand for diagnostic imaging services. Healthcare providers are constantly investing in improved imaging technology to cater to this growing generation, fueling market development.

Market players in the region are increasingly innovating advanced diagnostic imaging solutions, which are expected to contribute to the region's market share. Several organizations, hospitals, and healthcare institutes are conducting mobile health services in the region, which is expected to increase the adoption of advanced diagnostic imaging systems, which could contribute to the market growth.

For instance, in August 2024, DocGo Inc. launched an innovative mobile X-ray program in partnership with MinXray. The program launched in New York City to provide rapid and accessible chest X-rays for vulnerable populations and help identify active Tuberculosis ("TB") cases. These programs increase the usage of the systems. Thus, the above factors are expected to hold the region in a significant position in the market share.

Competitive Landscape

The global market players in the diagnostic imaging market are GE HealthCare, Siemens Healthineers AG, Carestream Health, Hitachi Medical Corporation, Canon Medical Systems Corporation, Hologic, Inc., Koninklijke Philips N.V., Fujifilm Holdings Corporation, Shimadzu Corporation, and Mindray, among others.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials and product pipelines and forecasts upcoming pharmaceutical advancements.
  • Type Performance & Market Positioning: Analyze product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: This covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyze competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient Type delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global diagnostic imaging market report would provide approximately 45 tables, 46 figures, and 180 pages.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Technology & Innovation: R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Market Introduction and Scope

  • 1.1. Objectives of the Report
  • 1.2. Report Coverage & Definitions
  • 1.3. Report Scope

2. Executive Insights and Key Takeaways

  • 2.1. Market Highlights and Strategic Takeaways
  • 2.2. Key Trends and Future Projections
  • 2.3. Snippet by Type
  • 2.4. Snippet by Application
  • 2.5. Snippet by End-User
  • 2.6. Snippet by Region

3. Dynamics

  • 3.1. Impacting Factors
    • 3.1.1. Drivers
      • 3.1.1.1. Increasing Incidence of Chronic Diseases
      • 3.1.1.2. Rising Innovation of Advanced Products
    • 3.1.2. Restraints
      • 3.1.2.1. High Costs of the Diagnostic Imaging Systems
      • 3.1.2.2. Lack of Skilled Professionals
    • 3.1.3. Opportunity
      • 3.1.3.1. Technological Advancements
    • 3.1.4. Impact Analysis

4. Strategic Insights and Industry Outlook

  • 4.1. Market Leaders and Pioneers
    • 4.1.1. Emerging Pioneers and Prominent Players
    • 4.1.2. Established leaders with largest selling Brand
    • 4.1.3. Market leaders with established Product
  • 4.2. CXO Perspectives
  • 4.3. Latest Developments and Breakthroughs
  • 4.4. Case Studies/Ongoing Research
  • 4.5. Regulatory and Reimbursement Landscape
    • 4.5.1. North America
    • 4.5.2. Europe
    • 4.5.3. Asia Pacific
    • 4.5.4. Latin America
    • 4.5.5. Middle East & Africa
  • 4.6. Porter's Five Forces Analysis
  • 4.7. Supply Chain Analysis
  • 4.8. Patent Analysis
  • 4.9. SWOT Analysis
  • 4.10. Unmet Needs and Gaps
  • 4.11. Recommended Strategies for Market Entry and Expansion
  • 4.12. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 4.13. Pricing Analysis and Price Dynamics
  • 4.14. Key Opinion Leaders

5. Diagnostic Imaging Market, By Type

  • 5.1. Introduction
    • 5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 5.1.2. Market Attractiveness Index, By Type
  • 5.2. MRI*
    • 5.2.1. Introduction
    • 5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
    • 5.2.3. Low-Field MRI Scanners
    • 5.2.4. High-Field MRI Scanners
    • 5.2.5. Mid-Field MRI Scanners
  • 5.3. X-Ray
    • 5.3.1. Analog Imaging
    • 5.3.2. Digital Imaging
  • 5.4. Nuclear Medicine
    • 5.4.1. Scintigraphy
    • 5.4.2. PET Imaging
    • 5.4.3. SPECT Imaging
  • 5.5. Ultrasound
    • 5.5.1. 2D Ultrasound
    • 5.5.2. 3D/4D Ultrasound
    • 5.5.3. Doppler Imaging
  • 5.6. Tomography
    • 5.6.1. High-End Slice CT Scanners
    • 5.6.2. Mid-End Slice CT Scanners
    • 5.6.3. Low-End Slice CT Scanners
  • 5.7. Tactile Imaging
  • 5.8. Functional Near Infrared Spectroscopy

6. Diagnostic Imaging Market, By Application

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 6.1.2. Market Attractiveness Index, By Application
  • 6.2. Orthopedic*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
    • 6.2.3. Arthritis
    • 6.2.4. Fractures and Dislocations
    • 6.2.5. Osteoporosis
    • 6.2.6. Spine Orthopedics
    • 6.2.7. Others
  • 6.3. Neurology
    • 6.3.1. Brain Tumors
    • 6.3.2. Traumatic Brain Injury
    • 6.3.3. Brain Stroke
    • 6.3.4. Others
  • 6.4. Oncology
    • 6.4.1. Breast Cancer
    • 6.4.2. Colorectal Cancer
    • 6.4.3. Lung Cancer
    • 6.4.4. Other Cancers
  • 6.5. Others

7. Diagnostic Imaging Market, By End User

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 7.1.2. Market Attractiveness Index, By End User
  • 7.2. Diagnostic Imaging Centers*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Hospitals
  • 7.4. Others

8. Diagnostic Imaging Market, By Regional Market Analysis and Growth Opportunities

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 8.1.2. Market Attractiveness Index, By Region
  • 8.2. North America
    • 8.2.1. Introduction
    • 8.2.2. Key Region-Specific Dynamics
    • 8.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 8.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 8.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 8.2.6.1. U.S.
      • 8.2.6.2. Canada
  • 8.3. Europe
    • 8.3.1. Introduction
    • 8.3.2. Key Region-Specific Dynamics
    • 8.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 8.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 8.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 8.3.6.1. Germany
      • 8.3.6.2. U.K.
      • 8.3.6.3. France
      • 8.3.6.4. Spain
      • 8.3.6.5. Italy
      • 8.3.6.6. Rest of Europe
  • 8.4. Latin America
    • 8.4.1. Introduction
    • 8.4.2. Key Region-Specific Dynamics
    • 8.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 8.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 8.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 8.4.6.1. Mexico
      • 8.4.6.2. Brazil
      • 8.4.6.3. Argentina
      • 8.4.6.4. Rest of Latin America
  • 8.5. Asia-Pacific
    • 8.5.1. Introduction
    • 8.5.2. Key Region-Specific Dynamics
    • 8.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 8.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 8.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 8.5.6.1. China
      • 8.5.6.2. India
      • 8.5.6.3. Japan
      • 8.5.6.4. South Korea
      • 8.5.6.5. Rest of Asia-Pacific
  • 8.6. Middle East and Africa
    • 8.6.1. Introduction
    • 8.6.2. Key Region-Specific Dynamics
    • 8.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 8.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

9. Competitive Landscape and Market Positioning

  • 9.1. Competitive Overview and Key Market Players
  • 9.2. Market Share Analysis and Positioning Matrix
  • 9.3. Strategic Partnerships, Mergers & Acquisitions
  • 9.4. Key Developments in Product Portfolios and Innovations
  • 9.5. Company Benchmarking

10. Company Profiles

  • 10.1. GE HealthCare*
    • 10.1.1. Company Overview
    • 10.1.2. Product Portfolio
      • 10.1.2.1. Product Description
      • 10.1.2.2. Product Key Performance Indicators (KPIs)
      • 10.1.2.3. Historic and Forecasted Product Sales
      • 10.1.2.4. Product Sales Volume
    • 10.1.3. Financial Overview
      • 10.1.3.1. Company Revenue's
      • 10.1.3.2. Geographical Revenue Shares
      • 10.1.3.3. Revenue Forecasts
    • 10.1.4. Key Developments
      • 10.1.4.1. Mergers & Acquisitions
      • 10.1.4.2. Key Product Development Activities
      • 10.1.4.3. Regulatory Approvals, etc.
    • 10.1.5. SWOT Analysis
  • 10.2. Siemens Healthineers AG
  • 10.3. Carestream Health
  • 10.4. Hitachi Medical Corporation
  • 10.5. Canon Medical Systems Corporation
  • 10.6. Hologic, Inc.
  • 10.7. Koninklijke Philips N.V.
  • 10.8. Fujifilm Holdings Corporation
  • 10.9. Shimadzu Corporation
  • 10.10. Mindray

LIST NOT EXHAUSTIVE

11. Assumption and Research Methodology

  • 11.1. Data Collection Methods
  • 11.2. Data Triangulation
  • 11.3. Forecasting Techniques
  • 11.4. Data Verification and Validation

12. Appendix

  • 12.1. About Us and Services
  • 12.2. Contact Us